Navigation Links
EnteroMedics Reports Second Quarter 2014 Financial Results
Date:8/7/2014

ks, uncertainties and other factors including our limited history of operations; our losses since inception and for the foreseeable future; our lack of commercial regulatory approval for our Maestro® System for the treatment of obesity in the United States or in any foreign market other than Australia and the European Community; our preliminary findings from our EMPOWER™ and ReCharge pivotal trials; our ability to comply with the Nasdaq continued listing requirements; our ability to commercialize our Maestro System; our dependence on third parties to initiate and perform our clinical trials; the need to obtain regulatory approval for any modifications to our Maestro System; physician adoption of our Maestro System and VBLOC® vagal blocking therapy; our ability to obtain third party coding, coverage or payment levels; ongoing regulatory compliance; our dependence on third party manufacturers and suppliers; the successful development of our sales and marketing capabilities; our ability to raise additional capital when needed; international commercialization and operation; our ability to attract and retain management and other personnel and to manage our growth effectively; potential product liability claims; potential healthcare fraud and abuse claims; healthcare legislative reform; and our ability to obtain and maintain intellectual property protection for our technology and products. These and additional risks and uncertainties are described more fully in the Company's filings with the Securities and Exchange Commission, particularly those factors identified as "risk factors" in the annual report on Form 10-K filed March 27, 2014. We are providing this information as of the date of this press release and do not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

Caution - Investigational device.  Limited by Federal (United States) law
'/>"/>

SOURCE EnteroMedics Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. EnteroMedics to Participate in Canaccord Genuity 34th Annual Growth Conference
2. EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call
3. Vanda Pharmaceuticals Reports Second Quarter 2014 Results
4. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 Second Quarter Financial Results
5. PTC Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update
6. Mylan Reports Second Quarter 2014 Adjusted Diluted EPS of $0.69, In Line With Guidance
7. Hill-Rom Reports Improved Fiscal Third Quarter Results; Updates Full-Year Guidance
8. Regulus Reports Second Quarter 2014 Financial Results and Recent Highlights
9. Depomed Reports Second Quarter 2014 Financial Results
10. BioScrip Reports Second Quarter 2014 Financial Results
11. Delcath Reports 2014 Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... -- A new report by Allied Market ... Opportunities, Growth and Forecast, 2014-2020", forecasts the global syphilis ... secondary syphilis testing would continue to be the largest ... , Middle East & ... 43% revenue share of the global syphilis testing market ...
(Date:5/28/2015)...  The recent flurry of PBM mergers and ... scrambling to identify a pharmacy benefit manager that ... retail pharmacy chain, or other potentially conflicting entity. ... Catamaran, Rite Aid,s $2 billion acquisition of EnvisionRx, ... $10 billion are just the latest examples of ...
(Date:5/28/2015)... WASHINGTON , May 28, 2015 ... resolving the Commission,s antitrust suit charging Cephalon, Inc. ... sleep-disorder drug Provigil. The settlement ensures that Teva ... will make a total of $1.2 billion available ... insurers, who overpaid because of Cephalon,s illegal conduct.  ...
Breaking Medicine Technology:Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 2Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 3Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 2Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 3FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics 2FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics 3
... Va. , Feb. 3 CEL-SCI Corporation ... Officer, will be presenting at the 2010 BIO CEO & Investor ... take place February 8-9 at the Waldorf=Astoria in ... Tuesday, February 9th , at 1:30 p.m. EST .  The ...
... , Feb. 3 Repligen Corporation (Nasdaq: RGEN ... from the United States Patent and Trademark Office for a patent ... structure to the commercial form of Protein A from Staphylococcus ... the world,s approved monoclonal antibodies . The patent, which ...
Cached Medicine Technology:CEL-SCI to Present at 12th Annual BIO CEO & Investor Conference 2Repligen Receives Notice of Allowance for Recombinant Protein A Patent 2Repligen Receives Notice of Allowance for Recombinant Protein A Patent 3
(Date:5/28/2015)... lifeIMAGE announced today that ... led by Cambia Health Solutions (Portland, Ore.), ... health care by creating a person-focused and economically sustainable ... for exchanging medical imaging, will use this financing to ... breadth of its network capabilities and implement the next ...
(Date:5/28/2015)... 2015 WebWatcher, the leading ... partnership with BeSure Consulting to help parents ... The partnership will combine BeSure Consulting’s online ... monitoring software solution. , Led by Internet ... passion is concentrated on teaching law enforcement ...
(Date:5/28/2015)... 2015 A bucket list should include ... Each item on the bucket list can be tiny, ... tasks that the owner wants to happen in their ... when it comes to making this list. Bucket ... publishing a book, seeing the Grand Canyon on horseback, ...
(Date:5/28/2015)... what your racquet can do for you but what kind ... the launch of their new digital campaign, HEAD introduces trick ... unique skill to HEAD Pro Players and consumers around the ... demonstrates how to gain more control over the racquet and ... tennis enthusiasts everywhere to join the show. , The digital ...
(Date:5/28/2015)... The MIT Sloan Center for Information ... IQ. Members of the MIT CISR research team interviewed ... develop the case study about Healthcare IQ’s business model ... case study, ‘Healthcare IQ: Competing as the “Switzerland” of ... as a hospital financial software provider through its evolution ...
Breaking Medicine News(10 mins):Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 2Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 4Health News:WebWatcher Partners with BeSure Consulting 2Health News:WebWatcher Partners with BeSure Consulting 3Health News:Tennis Artist Baffles Novak Djokovic - HEAD Launches Trick Shot Campaign “Frame & Play” 2Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 2Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 3
... industry-leading PBM technology solutions and, ... Compensation -, , , LISLE, IL, July 17 /PRNewswire-FirstCall/ - ... SXCI , TSX: SXC), a leading provider of technology and pharmacy ... Group has been awarded a contract to provide PBM solutions to ...
... , American Health Assistance Foundation Researcher and ... , CLARKSBURG, Md., July 17 ... host a special community screening and discussion of the HBO Series ... devastating disease, and to share tips and information on cutting edge research. ...
... Behavior problems, not additional caretaking, seem to cause the distress ... has tried to quell a 3-year-old,s temper tantrum knows that ... autism spectrum disorder to the mix and the likelihood of ... the July issue of the journal Autism suggests ...
... ... and Asthma Control in Kids (TRACK™) is the first validated, parent-administered asthma-control test for ... ... age can now answer five simple questions to determine if their child,s breathing problems ...
... outstrips gains seen in general population, study finds , FRIDAY, ... gotten much larger and faster than they were a century ... than the general population, say U.S. researchers. , Duke University ... runners who won world records since 1900 and then correlated ...
... PLAINVIEW, N.Y., July 17 Davis Vision, Inc., a ... already provided more than $200,000 to date in free vision care ... and eyeglasses have been provided to more than 1,500 people across ... our ,Focus on America, vision program to a variety of communities ...
Cached Medicine News:Health News:SXC Health Solutions announces contract with largest worker's compensation organization in the U.S. 2Health News:SXC Health Solutions announces contract with largest worker's compensation organization in the U.S. 3Health News:SXC Health Solutions announces contract with largest worker's compensation organization in the U.S. 4Health News:American Health Assistance Foundation & Asbury Methodist Village to Host Special Community Screenings and Discussion of HBO Series The Alzheimer's Project 2Health News:American Health Assistance Foundation & Asbury Methodist Village to Host Special Community Screenings and Discussion of HBO Series The Alzheimer's Project 3Health News:American Health Assistance Foundation & Asbury Methodist Village to Host Special Community Screenings and Discussion of HBO Series The Alzheimer's Project 4Health News:Parents of Children With Autism Report High Stress Levels 2Health News:Parents of Children With Autism Report High Stress Levels 3Health News:New Five-Question Test Helps Assess Asthma Control In Children Under Five Years Of Age 2Health News:New Five-Question Test Helps Assess Asthma Control In Children Under Five Years Of Age 3Health News:New Five-Question Test Helps Assess Asthma Control In Children Under Five Years Of Age 4Health News:Davis Vision Provides More Than $200,000 in Free Vision Care Services 2Health News:Davis Vision Provides More Than $200,000 in Free Vision Care Services 3
TOX/See is a 1-step, hand-held, point-of-care device for the qualitative detection of drug or drug metabolites in human urine....
Compact, bench-top analyser with minimal water volume requirements and easy waste management....
Compact benchtop clinical chemistry system...
... 350 Chemistry System offers easy operation, maintenance, and ... STAT, or back-up to the powerful VITROS 5,1 ... the job done right the first time. Its ... are efficient, dependable, and easy-to-use. The VITROS 350 ...
Medicine Products: